AstraZeneca and its partner Amgen Inc. (Amgen) announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for tezepelumab in patients with severe asthma, without an eosinophilic phenotype, who are receiving inhaled corticosteroids/long-acting beta2-agonists with or without oral corticosteroids and additional asthma controllers. Lesen Sie weiter auf: FDA Grants Breakthrough Therapy […]
Das Bundeskabinett hat am 29.07.2015 ein Gesetz gegen Korruption im Gesundheitswesen beschlossen. Dies ist eine Reaktion auf die Entscheidung des BGH vom 29.03.2012, wonach niedergelassene (Vertrags-)Ärzte weder als Amtsträger noch als Beauftragte der gesetzlichen Krankenkasse im Sinne der §§ 299; 331, 332 StGB anzusehen sind. Da auch andere Straftatbestände nicht einschlägig sind, bestand im medizinischen […]
The post Korruptionsstrafbarkeit im Gesundheitswesen – der neue § 299a StGB appeared first on LEX MEDICORUM.
The U.S. Food and Drug Administration is warning consumers and health care professionals about a voluntary recall of one lot of Montelukast Sodium Tablets – lot number MON17384, expiration 12/31/2019 – by Camber Pharmaceuticals, Inc., Piscataway, N.J. Sealed bottles labeled as montelukast sodium tablets, 10 milligram, 30-count bottle from Camber were found to instead contain […]
Since September 7th, there has been temporary supply of AUVI-Q® epinephrine auto-injectors available across pharmacies in Canada. This additional stock is meant to help mitigate the current ongoing supply constraints of the EpiPen® 0.3 mg dose. AUVI-Q auto-injectors were previously known as Allerject auto-injectors in Canada. Read our FAQs on the AUVI-Q temporary supply. We […]